Terry Gould Insider Profile
4 Followers
Terry Gould, Director, Ten Percent Owner at Corvus Pharmaceuticals, holds 256.78K shares in Icosavax (Ticker: ICVX), holds 1.81M shares in Aptinyx (Ticker: APTX), holds 3.28M shares in Corvus Pharmaceuticals (Ticker: CRVS).
Terry Gould's Trading History
| ICVXIcosavax | Aug 03, 2021 | ― | Uninformative Buy | ― | $3.93M | |
| APTXAptinyx | Jun 26, 2018 | ― | Uninformative Buy | ― | $173.88K | |
| CRVSCorvus Pharmaceuticals | Mar 13, 2018 | Director, Ten Percent Owner | Informative Buy | 5.00M | $34.85M | |
| OMEDOncoMed Pharma | Dec 02, 2015 | ― | Uninformative Buy | ― | $1.15M |
You May Also Like
Terry Gould insider profile FAQ
What is the percentage of profitable transactions made by Terry Gould?
The percentage of profitable transactions made by Terry Gould is 0%.
What is the average return per transaction made by Terry Gould?
The average return per transaction made by Terry Gould is -72.80%.
What stocks does Terry Gould hold?
Terry Gould holds: CRVS, OMED, APTX, ICVX stocks.
What was Terry Gould's most profitable transaction?
Terry Gould’s most profitable transaction was an Informative Buy of CRVS stock on March 13, 2018. The return on the trade was -60.20%.
What is Terry Gould's role in Corvus Pharmaceuticals?
Terry Gould's role in Corvus Pharmaceuticals is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
